AI assistant
Advanced Enzyme Technologies Limited — Regulatory Filings 2021
Mar 26, 2021
62369_rns_2021-03-26_bf57730d-ca3f-4888-ac85-e5b394390fb0.pdf
Regulatory Filings
Open in viewerOpens in your device viewer
March 26, 2021
BSE Limited National Stock Exchange of India Ltd. Department of Corporate Affairs Exchange Plaza, Plot No. C/1, G Block P. J. Towers, Dalal Street, Bandra-Kurla Complex, Bandra (E) Mumbai-400 001 Mumbai-400 051 Scrip ID-540025 Scrip Code-ADVENZYMES
Dear Sir/Madam,
Sub: Intimation of Analyst / Institutional Investor Meeting under the SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015
We wish to inform you that pursuant to SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the schedule of Analyst / Institutional Investor Meeting with the Company is as under:
| Date | Interaction With | Type & details |
|---|---|---|
| April 08, 2021 | Invesco Oppenheimer | Virtual Meeting, One to One |
Note: The aforesaid is subject to change. Changes may happen due to exigencies on the part of Fund/Company.
The aforesaid information is also being uploaded on the Company’s website.
You are requested to kindly take a note of the same.
Thanking you, Yours faithfully, For Advanced Enzyme Technologies Limited
SANJAY Digitally signed by SANJAY PRAKASH PRAKASH BASANTANI BASANTANI Date: 2021.03.26 14:02:17 +05'30'
Sanjay Basantani Company Secretary and Head – Legal